Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 752 Jan 1 – Oct 25, 2026
- Disclosed funding
- $25.9B 611 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
 AmpaCompany profile Ampa builds a portable, camera-guided transcranial magnetic stimulation system for clinicians providing depression care. Ampa builds a portable, camera-guided transcranial magnetic stimulation system for clinicians providing depression care. | Undisclosed | Undisclosed | Healthtech | United States | Investors | |
| UH Develops non-invasive bladder function monitoring medical devices | $11M | Seed | Healthtech | United States | Investors | |
| BM BlueWind MedicalCompany profile Develops implantable tibial neuromodulation devices for urgency urinary incontinence treatment Develops implantable tibial neuromodulation devices for urgency urinary incontinence treatment | $47.8M | Growth | Healthtech | United States | Investors Undisclosed | |
| MA Mongoose AICompany profile Provides governed AI agents for health plans to execute work across every interaction Provides governed AI agents for health plans to execute work across every interaction | Undisclosed | Seed+Seed | Healthtech | United States | Investors | |
| AG Avant GenomicsCompany profile Automates liquid biopsy sample preparation for consistent, scalable cancer DNA extraction Automates liquid biopsy sample preparation for consistent, scalable cancer DNA extraction | >$3M | Seed | Healthtech, Biotech | United States | Investors | |
| Q QuartzBioCompany profile Provides AI-powered sample and biomarker intelligence platform for clinical-stage biopharma Provides AI-powered sample and biomarker intelligence platform for clinical-stage biopharma | Undisclosed | Growth | Healthtech | United States | Investors | |
| 9 9amHealthCompany profile AI-enabled virtual specialty care platform for managing high-cost chronic conditions AI-enabled virtual specialty care platform for managing high-cost chronic conditions | $26M | Series B | Healthtech | United States | Investors | |
| AI Anomaly InsightsCompany profile Analyzes healthcare transactions in real time to identify payer behavior patterns and recover provider revenue Analyzes healthcare transactions in real time to identify payer behavior patterns and recover provider revenue | $17M | Series B | Healthtech | United States | Investors | |
| U UroMemsCompany profile Develops innovative, implantable mechatronics technology to treat stress urinary incontinence Develops innovative, implantable mechatronics technology to treat stress urinary incontinence | $60M | StrategicUndisclosed | Healthtech | France | Investors | |
 Autoimmunity BioSolutionsCompany profile Genetically guided therapies targeting elevated soluble IL7 receptor levels in autoimmune disease. Genetically guided therapies targeting elevated soluble IL7 receptor levels in autoimmune disease. | $1M | Seed extensionSeed | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.